270 related articles for article (PubMed ID: 18393673)
1. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel.
Prokhorova TA; Harkness LM; Frandsen U; Ditzel N; Schrøder HD; Burns JS; Kassem M
Stem Cells Dev; 2009; 18(1):47-54. PubMed ID: 18393673
[TBL] [Abstract][Full Text] [Related]
2. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny.
Gropp M; Shilo V; Vainer G; Gov M; Gil Y; Khaner H; Matzrafi L; Idelson M; Kopolovic J; Zak NB; Reubinoff BE
PLoS One; 2012; 7(9):e45532. PubMed ID: 23049812
[TBL] [Abstract][Full Text] [Related]
3. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential.
Lees JG; Lim SA; Croll T; Williams G; Lui S; Cooper-White J; McQuade LR; Mathiyalagan B; Tuch BE
Regen Med; 2007 May; 2(3):289-300. PubMed ID: 17511565
[TBL] [Abstract][Full Text] [Related]
5. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.
Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR
Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593
[TBL] [Abstract][Full Text] [Related]
6. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.
Choo A; Ngo AS; Ding V; Oh S; Kiang LS
Methods Cell Biol; 2008; 86():15-28. PubMed ID: 18442642
[TBL] [Abstract][Full Text] [Related]
7. Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells.
Aldahmash A; Atteya M; Elsafadi M; Al-Nbaheen M; Al-Mubarak HA; Vishnubalaji R; Al-Roalle A; Al-Harbi S; Manikandan M; Matthaei KI; Mahmood A
Asian Pac J Cancer Prev; 2013; 14(10):5705-11. PubMed ID: 24289566
[TBL] [Abstract][Full Text] [Related]
8. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
Gordeeva OF; Nikonova TM
Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
[TBL] [Abstract][Full Text] [Related]
9. The tumorigenicity of human embryonic stem cells.
Blum B; Benvenisty N
Adv Cancer Res; 2008; 100():133-58. PubMed ID: 18620095
[TBL] [Abstract][Full Text] [Related]
10. Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells.
Ng VY; Ang SN; Chan JX; Choo AB
Stem Cells; 2010 Jan; 28(1):29-35. PubMed ID: 19785009
[TBL] [Abstract][Full Text] [Related]
11. Functional assays for human embryonic stem cell pluripotency.
O'Connor MD; Kardel MD; Eaves CJ
Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
[TBL] [Abstract][Full Text] [Related]
12. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency.
Gertow K; Przyborski S; Loring JF; Auerbach JM; Epifano O; Otonkoski T; Damjanov I; Ahrlund-Richter L
Curr Protoc Stem Cell Biol; 2007 Oct; Chapter 1():Unit1B.4. PubMed ID: 18785162
[TBL] [Abstract][Full Text] [Related]
13. The teratoma assay: an in vivo assessment of pluripotency.
Wesselschmidt RL
Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
[TBL] [Abstract][Full Text] [Related]
14. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected].
Lu SJ; Kelley T; Feng Q; Chen A; Reuveny S; Lanza R; Oh SK
Regen Med; 2013 Jul; 8(4):413-24. PubMed ID: 23826696
[TBL] [Abstract][Full Text] [Related]
15. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice.
Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y
Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord mesenchymal stem cells support nontumorigenic expansion of human embryonic stem cells.
Ding DC; Shyu WC; Lin SZ; Liu HW; Chiou SH; Chu TY
Cell Transplant; 2012; 21(7):1515-27. PubMed ID: 22732188
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of human embryonic stem cell differentiation into teratomas.
Blum B; Benvenisty N
Stem Cells; 2007 Aug; 25(8):1924-30. PubMed ID: 17464084
[TBL] [Abstract][Full Text] [Related]
18. A novel culture technique for human embryonic stem cells using porous membranes.
Kim S; Ahn SE; Lee JH; Lim DS; Kim KS; Chung HM; Lee SH
Stem Cells; 2007 Oct; 25(10):2601-9. PubMed ID: 17628020
[TBL] [Abstract][Full Text] [Related]
19. A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells.
Mollamohammadi S; Taei A; Pakzad M; Totonchi M; Seifinejad A; Masoudi N; Baharvand H
Hum Reprod; 2009 Oct; 24(10):2468-76. PubMed ID: 19602515
[TBL] [Abstract][Full Text] [Related]
20. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
